Autoinflammatory & rare systemic diseases

Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults

Ann Rheum DisPublished Retrospective cohort study

Authors' conclusion

The incidence of IgG4-RD is similar to that of systemic rheumatic diseases such as ANCA-associated vasculitis and systemic sclerosis but may be increasing as familiarity with this diagnosis grows.

Study context

Population
Commercially insured adults in the USA, Optum Clinformatics Data Mart Database, 2009–2021 (mean age 56.5 years; 57.6% female; 66% White)524 igG4-related disease (IgG4-RD) cases identified
Participants
515 vs 5,160
Exposure
IgG4-RD vs matched non-IgG4-RD population
  • IgG4-RDn = 515
  • Comparatorsn = 5,160reference
Outcome
Incidence rate and prevalence of IgG4-RD, standardised to the US population by age and sex
Follow-up
2015–2019
Methodological detailsclaims-based, validated algorithm, standardised to US population by age and sex, matched 1:10 on age, sex, race/ethnicity and encounter date, Cox proportional hazards models
  • Claims-based
  • Validated algorithm
  • Standardised to US population by age and sex
  • Matched 1:10 on age, sex, race/ethnicity and encounter date
  • Cox proportional hazards models

Main finding

As reported in the abstract

Incidence and prevalence of IgG4-RD

Incidence, 2015

0.78 per 100 000 person-years

Incidence, 2019

1.39 per 100 000 person-years

Point prevalence on 1 January 2019

5.3/100 000 persons

Observational data: associations, not effects.

Further findings

OutcomeIgG4-RDComparatorsaHR (95% CI)
Mortality · During follow-upmortality rate 3.42 /100 person-yearsmortality rate 1.46 /100 person-years2.51 (1.76–3.56)
  • Mortality: matched 1:10

Original publication

Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults. Ann Rheum Dis. Published 3 May 2023. doi:10.1136/ard-2023-223950

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.